Temodar
Temodar ingredients
| Active ingredient | Strength |
|---|---|
| Temozolomide | 180 mg/1, 140 mg/1, 5 mg/1, 20 mg/1, 2.5 mg/mL, 250 mg/1 |
What Temodar is used for
The FDA lists the approved uses on the official label (below). In the EU, temozolomide is approved as Temodal for:
Temodal hard capsules is indicated for the treatment of: adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment; children from the age of three years, adolescents and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Temodar
- Generic name
- Temozolomide
- Made by
- Merck Sharp & Dohme LLC
- Forms
- Capsule, Injection, Powder, Lyophilized, For Solution
- Given
- Intravenous, Oral
- Drug class
- Alkylating Drug
- FDA approval
- New drug application (NDA) NDA021029
- On the US market since
- 1999
Official information
- Temodar prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Temozolomide)
In India
- Temozolomide: 107 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Temodar?
Temodar (Temozolomide) is a cancer medicine made by Merck Sharp & Dohme LLC, approved by the US FDA.
What are the ingredients of Temodar?
Temodar contains Temozolomide (180 mg/1, 140 mg/1, 5 mg/1, 20 mg/1, 2.5 mg/mL, 250 mg/1).
Is Temodar approved in Europe?
The same active substance is approved in the EU as Temodal.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA